Thomas Ciulla

Insider Reports History

Entity
Individual
Location
C/O Clearside Biomedical, Inc., 900 North Point Parkway, Suite 200, Alpharetta, GA
Signature
/s/ Thomas Ciulla
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Ciulla:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Clearside Biomedical, Inc. Chief Medical Officer Common Stock 292K $371K $1.27 Jan 20, 2023 Direct
Viridian Therapeutics, Inc.\DE Chief Medical Officer Common Stock 762 $16K $21.00 Jan 3, 2024 Direct
Viridian Therapeutics, Inc.\DE Chief Medical Officer Stock Option (Right to Buy) 50K Feb 5, 2024 Direct

Insider Reports Filed by Thomas Ciulla

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VRDN Viridian Therapeutics, Inc.\DE Feb 5, 2024 1 $0 4 Feb 7, 2024 Chief Medical Officer
VRDN Viridian Therapeutics, Inc.\DE Jan 3, 2024 0 $0 3 Jan 12, 2024 Chief Medical Officer
CLSD Clearside Biomedical, Inc. Jan 20, 2023 1 -$20.1K 4 Jan 20, 2023 Chief Medical Officer
CLSD Clearside Biomedical, Inc. Jan 10, 2023 1 -$3.52K 4 Jan 11, 2023 Chief Medical Officer
CLSD Clearside Biomedical, Inc. Jan 4, 2023 3 $11K 4 Jan 6, 2023 Chief Medical Officer
CLSD Clearside Biomedical, Inc. Jan 18, 2022 2 $0 4/A Jan 28, 2022 Chief Medical Officer
CLSD Clearside Biomedical, Inc. Sep 21, 2021 1 -$16.4K 4 Sep 23, 2021 Chief Medical Officer